Clinical trial
Comparison of Serum Thromboxane B2 and Platelet Function Testing With the Multiplate® Device as Measures of Aspirin Resistance in Hong Kong Chinese Patients With Increased Cardiovascular Risk With Stable Coronary Heart Disease
NCT04863053 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Serum Thromboxane B2 and Platelet Function Testing With the Multiplate® Device as Measures of Aspirin Resistance in Hong Kong Chinese Patients With Increased Cardiovascular Risk With Stable Coronary Heart Disease
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 2, 2015
- Completion date
- April 1, 2021
- Enrollment
- 266 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.